| Literature DB >> 28450136 |
Art Bracey1, Aryeh Shander2, Solomon Aronson3, Bradley A Boucher4, Domenico Calcaterra5, Michael W A Chu6, Richard Culbertson7, Karim Jabr8, Henrik Kehlet9, Omar Lattouf10, S Chris Malaisrie11, C David Mazer12, Martin M Oberhoffer13, Sherri Ozawa14, Theolyn Price15, Todd Rosengart16, Bruce D Spiess17, Giuseppe Turchetti18.
Abstract
Topical hemostatic agents are used in conjunction with conventional procedures to reduce blood loss. They are often used in cardiothoracic surgery, which is particularly prone to bleeding risks. Variation in their use exists because detailed policy and practice guidelines reflecting the current medical evidence have not been developed to promote best surgical practice in this setting. To address this need, the Society for the Advancement of Blood Management convened an International Hemostatic Expert Panel. This article reviews the available literature and sets out evidence-based recommendations for the use of topical hemostatic agents in cardiothoracic surgery.Entities:
Mesh：
Substances：
Year: 2017 PMID： 28450136 DOI： 10.1016/j.athoracsur.2017.01.096
Source DB: PubMed Journal: Ann Thorac Surg ISSN： 0003-4975 Impact factor: 4.330